These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Pathogenetic mechanisms of cardiac allograft vasculopathy--impact of nitric oxide. Koglin J Z Kardiol; 2000; 89 Suppl 9():IX/24-7. PubMed ID: 11151787 [TBL] [Abstract][Full Text] [Related]
10. Vascular cell adhesion molecule-1 is induced on vascular endothelia and medial smooth muscle cells in experimental cardiac allograft vasculopathy. Ardehali A; Laks H; Drinkwater DC; Ziv E; Drake TA Circulation; 1995 Aug; 92(3):450-6. PubMed ID: 7543379 [TBL] [Abstract][Full Text] [Related]
11. Bone marrow-derived AXL tyrosine kinase promotes mitogenic crosstalk and cardiac allograft vasculopathy. Glinton K; DeBerge M; Fisher E; Schroth S; Sinha A; Wang JJ; Wasserstrom JA; Ansari MJ; Zhang ZJ; Feinstein M; Leventhal JR; Forbess JM; Lomasney J; Luo X; Thorp EB J Heart Lung Transplant; 2021 Jun; 40(6):435-446. PubMed ID: 33846079 [TBL] [Abstract][Full Text] [Related]
12. The pathogenesis of coronary arteriosclerosis ("chronic rejection") in transplanted hearts. Libby P; Tanaka H Clin Transplant; 1994 Jun; 8(3 Pt 2):313-8. PubMed ID: 7520306 [TBL] [Abstract][Full Text] [Related]
13. Salusin-β Promotes Vascular Smooth Muscle Cell Migration and Intimal Hyperplasia After Vascular Injury via ROS/NFκB/MMP-9 Pathway. Sun HJ; Zhao MX; Ren XS; Liu TY; Chen Q; Li YH; Kang YM; Wang JJ; Zhu GQ Antioxid Redox Signal; 2016 Jun; 24(18):1045-57. PubMed ID: 26952533 [TBL] [Abstract][Full Text] [Related]
14. Cyclic adenosine monophosphate response-element binding protein activation by mitogen-activated protein kinase-activated protein kinase 3 and four-and-a-half LIM domains 5 plays a key role for vein graft intimal hyperplasia. Nakanishi K; Saito Y; Azuma N; Sasajima T J Vasc Surg; 2013 Jan; 57(1):182-93, 193.e1-10. PubMed ID: 23127979 [TBL] [Abstract][Full Text] [Related]
15. A novel promising therapy for vein graft restenosis: overexpressed Nogo-B induces vascular smooth muscle cell apoptosis by activation of the JNK/p38 MAPK signaling pathway. Zheng H; Xue S; Lian F; Wang YY Med Hypotheses; 2011 Aug; 77(2):278-81. PubMed ID: 21612877 [TBL] [Abstract][Full Text] [Related]
16. MMP-14 promotes VSMC migration via up-regulating CD44 expression in cardiac allograft vasculopathy. Yan D; Liu X; Hua L; Wu K; Sha X; Zhao J; Yang C; Zhang C; Shi J; Wu X Pathol Res Pract; 2016 Dec; 212(12):1119-1125. PubMed ID: 27712978 [TBL] [Abstract][Full Text] [Related]
17. Implication for transglutaminase 2-mediated activation of β-catenin signaling in neointimal vascular smooth muscle cells in chronic cardiac allograft rejection. Beazley KE; Zhang T; Lima F; Pozharskaya T; Niger C; Tzitzikov E; Azimzadeh AM; Nurminskaya M J Heart Lung Transplant; 2012 Sep; 31(9):1009-17. PubMed ID: 22694852 [TBL] [Abstract][Full Text] [Related]
18. Expression of allograft inflammatory factor-1 is a marker of activated human vascular smooth muscle cells and arterial injury. Autieri MV; Carbone C; Mu A Arterioscler Thromb Vasc Biol; 2000 Jul; 20(7):1737-44. PubMed ID: 10894811 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of graft coronary arteriosclerosis after heart transplantation. Soukiasian HJ; Czer LS; Wang HM; Luthringer D; Wang C; Kamlot A; Quartel A; Trento A Am Surg; 2004 Oct; 70(10):833-40. PubMed ID: 15529833 [TBL] [Abstract][Full Text] [Related]
20. Effects of everolimus and HLA-G on cellular proliferation and neutrophil adhesion in an in vitro model of cardiac allograft vasculopathy. Mociornita AG; Adamson MB; Tumiati LC; Ross HJ; Rao V; Delgado DH Am J Transplant; 2018 Dec; 18(12):3038-3044. PubMed ID: 29985558 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]